Arthritis Pain Relief

Description

Acetaminophen is an analgesic and antipyretic agent formulated as extended-release tablets, each containing 650 mg of the active ingredient. These gelatin-coated tablets are designed for the temporary relief of minor arthritis pain. The product is available in a package containing 20 geltabs, providing a convenient dosage form for patients requiring pain management.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including muscular aches, backache, headache, toothache, the common cold, minor pain of arthritis, and premenstrual and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults are advised to take 2 geltabs every 8 hours as needed. Each geltab should be swallowed whole; it is important not to crush, chew, split, or dissolve the geltabs. Prior to swallowing each geltab, the patient should take a sip of water and wash it down with additional water, up to a full 8 oz. glass. The maximum dosage should not exceed 6 geltabs within a 24-hour period. Furthermore, the use of this medication should not extend beyond 10 days unless directed by a healthcare professional.

For individuals under 18 years of age, it is recommended to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

• Patients with difficulty swallowing large tablets or capsules should not use this product, as it may pose a risk of choking. This is particularly relevant for individuals over the age of 65, who may experience increased difficulty in swallowing.

• Individuals with a known allergy to acetaminophen or any of the inactive ingredients in this formulation should avoid use to prevent allergic reactions.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen. Healthcare professionals should advise patients to adhere strictly to the recommended dosage, which is a maximum of 6 geltabs within a 24-hour period. Patients should be cautioned against the concurrent use of other medications containing acetaminophen and the consumption of three or more alcoholic drinks daily while using this product, as these factors significantly increase the risk of liver injury.

Before initiating treatment, it is essential for patients to consult a healthcare provider if they have a history of liver disease. Additionally, patients taking the anticoagulant warfarin should seek guidance from a doctor or pharmacist prior to use, as potential interactions may necessitate closer monitoring.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted at 1-800-222-1222. Prompt medical attention is crucial for both adults and children, even in the absence of noticeable symptoms.

Patients should be instructed to discontinue use and consult a healthcare professional if any of the following occur: worsening pain or pain lasting more than 10 days, fever that worsens or persists for more than 3 days, the emergence of new symptoms, the presence of redness or swelling, or if a tablet becomes lodged in the throat. These symptoms may indicate a serious underlying condition that requires further evaluation.

Side Effects

Patients using this product should be aware of the potential for serious adverse reactions, particularly related to liver health. The product contains acetaminophen, and severe liver damage may occur if patients exceed the maximum daily dosage of 6 geltabs within a 24-hour period, use it in conjunction with other medications containing acetaminophen, or consume 3 or more alcoholic drinks daily while using this product.

Patients are advised not to use this product if they are currently taking any other drug that contains acetaminophen, whether prescription or nonprescription. Individuals who have difficulty swallowing large tablets or capsules, particularly those over the age of 65, should also refrain from using this product. Additionally, patients with a known allergy to acetaminophen or any of the inactive ingredients in this formulation should avoid its use.

Before using this product, patients should consult a doctor if they have liver disease or are taking the blood-thinning medication warfarin.

Patients are instructed to discontinue use and seek medical advice if they experience worsening pain that lasts more than 10 days, a fever that persists for more than 3 days, the emergence of new symptoms, the presence of redness or swelling, or if the tablet becomes lodged in the throat, as these may indicate a serious condition.

In the event of an overdose, it is critical for patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt medical attention is essential for both adults and children, even if no signs or symptoms are initially apparent.

Drug Interactions

The concomitant use of acetaminophen with warfarin may elevate the risk of bleeding due to the anticoagulant effects of warfarin. It is advisable to monitor patients closely for signs of increased bleeding and to consider dosage adjustments of warfarin as necessary.

Additionally, acetaminophen should not be used in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. This precaution is essential to avoid the risk of acetaminophen overdose, which can lead to severe liver damage.

Packaging & NDC

Below are the non-prescription pack sizes of Arthritis Pain Relief (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 18 years of age should consult a healthcare professional prior to use. It is essential to assess the appropriateness of treatment and dosage for this population.

Geriatric Use

Elderly patients, particularly those aged 65 and older, may experience difficulty swallowing the tablets. It is important for healthcare providers to consider this when prescribing the medication to geriatric patients, as alternative formulations may be necessary to ensure proper administration.

Additionally, it is advised that elderly patients consult a healthcare professional prior to use if they have a history of liver disease. This precaution is essential due to the potential for altered drug metabolism and increased risk of adverse effects in this population.

Furthermore, geriatric patients who are concurrently taking the anticoagulant warfarin should seek guidance from a doctor or pharmacist before initiating treatment with this medication. The interaction between these drugs may necessitate careful monitoring and possible dose adjustments to mitigate the risk of bleeding complications.

Overall, careful consideration and consultation are recommended for elderly patients to ensure safe and effective use of the medication.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure appropriate management and consideration of any potential risks.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have concurrent liver disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of renal impairment. Careful evaluation of the patient's overall health status is recommended to ensure safe and effective use of the medication.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical that patients do not exceed the maximum daily dosage of 6 geltabs within a 24-hour period. Additionally, patients should avoid concomitant use with other medications containing acetaminophen, as this may further increase the risk of liver injury.

Patients with compromised liver function are advised to consult a healthcare professional prior to using this product, particularly if they have a history of liver disease. Furthermore, it is recommended that patients limit alcohol consumption to fewer than 3 alcoholic drinks per day while using this product to mitigate the risk of liver damage. Regular monitoring of liver function may be warranted in patients with existing liver conditions to ensure safety and efficacy during treatment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt medical intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the severity of symptoms may vary, and early recognition and management are essential to mitigate potential complications. It is recommended that healthcare providers monitor the patient closely and initiate appropriate supportive care as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified rare cases of severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, associated with the use of acetaminophen. Additionally, reports of acute liver failure have been noted in patients taking acetaminophen, particularly among those with underlying liver disease or those exceeding the recommended dosage. Instances of allergic reactions, including anaphylaxis, have also been documented following acetaminophen use. Furthermore, there have been reports of renal impairment and acute kidney injury in patients using acetaminophen, especially in individuals with pre-existing kidney conditions or those consuming high doses.

Patient Counseling

Healthcare providers should advise patients on the importance of seeking immediate medical assistance in the event of an overdose. Patients should be informed to contact a Poison Control Center at 1-800-222-1222 without delay. It is crucial to emphasize that prompt medical attention is necessary for both adults and children, even if they do not exhibit any signs or symptoms of overdose. This proactive approach can significantly impact the outcome in such situations.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which can be found on the packaging. It is essential to store the product at a temperature range of 20 to 25° C (68 to 77° F) to maintain its efficacy. Care should be taken to avoid high humidity conditions during storage. For reference, the batch number and expiration date are located on the end panel of the packaging.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Arthritis Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)